Special Products Ltd is pleased to announce that Epistatus 10mg Oromucosal Solution, Midazolam, is now available to prescribe. The NHS price for a single 10mg in 1mL prefilled syringe is £45.76.
Epistatus is licensed for use in the treatment of prolonged, acute convulsive seizures in children and adolescents aged 10 to less than 18 years, who have been diagnosed with epilepsy.
Buccal midazolam is recommended by NICE for the management of prolonged acute convulsive seizures, and is preferred by most patients and carers compared to the administration of rectal diazepam.
Epistatus is presented “ready-to-use” in a novel, pre-filled, single-dose syringe, to provide carers with the confidence that they are administering the correct dose. The pre-filled syringe is contained within a specially-designed, secure and tamper-evident protective packaging.
In response to market research and insights, Special Products Ltd has invested heavily in the development of this new bespoke syringe, which is designed to allow simple administration of the dose into the buccal cavity.
Community Pharmacists can obtain Epistatus 10mg/1mL pre-filled syringes exclusively via Alliance Healthcare. For further information on Epistatus 10mg oromucosal midazolam pre-filled syringes visit www.epistatus.co.uk